发明名称 HEPATOCYTE NUCLEAR FACTOR 4alpha MODULATOR COMPOUNDS
摘要 The present invention is directed to hepatocyte nuclear factor 4alpha (HNF-4alpha) receptor modulator compounds. This invention is also directed to pharmaceutical compositions containing such compounds as well as methods of using such compounds and pharmaceutical compositions for modulating HNF-4alpha receptors as well as processes mediated by HNF-4alpha receptors. Also provided are methods of making such compounds and pharmaceutical compositions, as well as intermediates used in their synthesis.
申请公布号 WO2005017185(A3) 申请公布日期 2005.07.14
申请号 WO2004US22907 申请日期 2004.07.16
申请人 LIGAND PHARMCEUTICALS INCORPORATED;MICHELLYS, PIERRE;CHEN, JYUN-HUNG;MAPES, CHRISTOPHER;RUPPAR, DANIEL;KARANEWSKY, DONALD;THOMPSON, ANTHONY 发明人 MICHELLYS, PIERRE;CHEN, JYUN-HUNG;MAPES, CHRISTOPHER;RUPPAR, DANIEL;KARANEWSKY, DONALD;THOMPSON, ANTHONY
分类号 A61K31/075;A61K31/35;A61K31/385;A61K31/47;C07C41/00;C07D215/00;C07D215/16;C07D311/04;C07D335/04;C12Q 主分类号 A61K31/075
代理机构 代理人
主权项
地址